Using a CGM in pregnancy and postpartum for gestational diabetes
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether using a continuous glucose monitor (CGM) during pregnancy and after delivery helps women with gestational diabetes. It aims to see if the Dexcom G7 can improve health outcomes for both you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gestational diabetes during this pregnancy
- You are 18 years old or older
- Your doctor has prescribed the Dexcom G7 continuous glucose monitor
- You did not have diabetes before this pregnancy
- You do not have a known allergy to skin adhesives
- You are not taking oral steroids regularly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a new continuous glucose monitoring (CGM) system can help find and treat gestational diabetes (high blood sugar during pregnancy) early. Women in early pregnancy will use a special sensor to track their glucose, which may help prevent problems for mother and baby.
This study tests a continuous glucose monitor (a small patch that tracks your blood sugar) for a few weeks after you give birth. It aims to see if this tool can help women who recently had gestational diabetes better understand their blood sugar levels after delivery.
This study tests a continuous glucose monitor (a small sensor that tracks your blood sugar) after pregnancy in people who had gestational diabetes. It aims to help you stay healthy and manage your blood sugar levels after giving birth.
This study uses a continuous glucose monitor (a small sensor that tracks your blood sugar) after you give birth to see if your blood sugar levels return to normal. It may help detect early signs of type 2 diabetes and guide your postpartum care.
This study tests whether using a continuous glucose monitor (a small sensor that tracks your blood sugar) along with support from others can help prevent or manage high blood sugar during pregnancy. It is for pregnant women under 20 weeks who have certain risk factors for gestational diabetes.
This study compares a continuous glucose monitor (CGM) to standard finger-prick testing for managing gestational diabetes. It aims to see if the CGM can improve blood sugar control and maternal outcomes.
Hear when a new Gestational Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.